Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Trends, and Forecasts 2020 - 2030

  • Single User License $3500

Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Trends, and Forecasts 2020 - 2030

Status : May, 2021 | Pharmaceutical

Report Digest


Drug Discovery Informatics Market: Overview

The global market for drug discovery informatics is expected to witness notable growth on account of the rising advancements in web services and web computing services. In addition to this, the rising adoption of in-silicon modeling tools will further add impetus to the growth of the market in the forecast period, set between 2020 and 2030. Drug discovery programming can be used to acquire market knowledge inferable from a few preferences, for example, fast drug plan and blend, effective following of sickness development, and information respectability the board, has expanded essentially among the scientists in the future years, thereby driving the business development.

The global drug discovery informatics market is classified on the basis of workflow, mode, services, and geography. In terms of workflow, the global market is grouped into development informatics, and discovery informatics, each of which are further sub-divided into smaller sections. The discovery informatics segment is bifurcated into lead generation and validation, identification & assay development informatics. The development informatics segment is further grouped into Phase IB/2, Phase IA, FHD Preparation, and lead optimization. In terms of mode, the global drug discovery informatics market is bifurcated into in-house, and outsourced. Based on service, the market is categorized into clinical trial data management, docking, molecular modeling, sequence analysis platforms, and other services.

The report on the global drug discovery informatics market is based on a qualitative and quantitative analysis of the market emphasizing on market drivers, restraints, trends, innovations, and future opportunities. The report also highlights the table of segmentation and mentions the name of leading segment with supporting factors. It also focuses on the list of players operating in the market and their key strategies adopted to attract higher revenues in the years to come. The report is available for sale on the company website.

Drug Discovery Informatics Market: Competitive Landscape

Players operating in the global drug discovery informatics market are indulging in joint ventures and partnerships so as to gain a competitive edge in the overall market. In addition to this, players are also investing in research and development of better data platform.

Some of the key vendors of this market include;

  • Illumina Inc.
  • Accenture,
  • Albany Molecular Research Inc.
  • Novo Informatics Pvt Ltd.
  • Jubilant Biosys
  • Collaborative Drug Discovry Inc.
  • Infosys Ltd.
  • Certara
  • Agilent Technologies Inc.
  • Oracle, ChemAxon Ltd.
  • Selvita
  • Eurofins DiscoverX Products
  • Charles River Laboratories
  • Boehringer Ingelheim International GmbH

Drug Discovery Informatics Market: Recent Innovations

The increasing investment on research and development on informatics by biotechnological and pharmaceutical industries are likely to aid in expansion of the global drug discovery informatics market. In addition to this, the market is also driven by the rising focus on drug discovery informatics software. On the contrary, factors such as high installation and running costs may pose a major challenge to the market in the coming years. Nevertheless, the growing biotechnology sector and emerging markets in this sector will help aid in expansion of the global market in the coming years.

Drug Discovery Informatics Market: Regional Analysis

North America represented the biggest portion of the worldwide drug discovery informatics market, firmly followed by Europe. The huge portion of North America in the worldwide market can be ascribed to the presence of grounded CROs, rising R&D consumption by drug and biopharmaceutical organizations

The Asia Pacific is assessed to develop at the most noteworthy CAGR during the conjecture time frame. Factors like the fast development in the drug and biopharmaceutical industry, rising number of CROs, and the presence of less-severe guidelines for drug discovery measures

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?